<DOC>
	<DOCNO>NCT01832389</DOCNO>
	<brief_summary>The objective study determine whether goal-directed therapy reduce incidence delay cerebral ischaemia aneurysmal subarachnoid haemorrhage .</brief_summary>
	<brief_title>Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage</brief_title>
	<detailed_description>The aneurysmal subarachnoid haemorrhage ( SAH ) frequent dangerous worldwide cause stroke . A typical complication present delay cerebral ischemia consequence cerebral vasospasms , occur 46 % case . The Triple-H-therapy ( Hypervolaemia , Hypertension Haemodilution ) favour prevent ischaemic complication vasospasm long time . However recently , focus mainly hypertension , recommend maintain normovolaemia . The debate assure normovolaemia still go , therefore , study design examine whether PiCCO-controlled haemodynamic monitoring goal-directed therapy reduce incidence delay cerebral ischaemia SAH . The present study prospective randomize control clinical study . Patients older 18 year aneurysmal SAH enrol . They divide two group : control group `` C '' PiCCO group `` P '' . Both group treat accord current guideline . In addition , group P volume catecholamine therapy control mean PiCCO-controlled monitoring algorithm . The primary end point number occur delayed cerebral ischaemia per patient . Secondary end point neurological , pulmonary , cardiovascular , renal , hepatic complication well electrolyte serum glucose disturbance , sepsis , mortality , length hospital intensive care unit stay amount volume catecholamine administer . All participant contact three month discharge , health status determine use GOS ( Glasgow Outcome Scale ) .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<criteria>aneurysmal Subarachnoid Haemorrhage ( SAH ) Age â‰¥ 18 year traumatic SAH congestive heart failure severe diseases aorta aortic valve pregnancy calcium antagonist intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Subarachnoid Haemorrhage ( SAH )</keyword>
	<keyword>vasospasm</keyword>
	<keyword>delay cerebral ischaemia ( DCI )</keyword>
	<keyword>goal direct therapy ( GDT )</keyword>
	<keyword>Pulse Contour Cardiac Output ( PiCCO )</keyword>
</DOC>